These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas. Hummel TR; Salloum R; Drissi R; Kumar S; Sobo M; Goldman S; Pai A; Leach J; Lane A; Pruitt D; Sutton M; Chow LM; Grimme L; Doughman R; Backus L; Miles L; Stevenson C; Fouladi M; DeWire M J Neurooncol; 2016 Mar; 127(1):53-61. PubMed ID: 26626490 [TBL] [Abstract][Full Text] [Related]
16. H3 K27M-altered glioma and diffuse intrinsic pontine glioma: Semi-systematic review of treatment landscape and future directions. van den Bent M; Saratsis AM; Geurts M; Franceschi E Neuro Oncol; 2024 May; 26(Supplement_2):S110-S124. PubMed ID: 38102230 [TBL] [Abstract][Full Text] [Related]
17. A pilot radiogenomic study of DIPG reveals distinct subgroups with unique clinical trajectories and therapeutic targets. Zhu X; Lazow MA; Schafer A; Bartlett A; Senthil Kumar S; Mishra DK; Dexheimer P; DeWire M; Fuller C; Leach JL; Fouladi M; Drissi R Acta Neuropathol Commun; 2021 Jan; 9(1):14. PubMed ID: 33431066 [TBL] [Abstract][Full Text] [Related]